{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "19018 Inpatient Management of Parkinsons Disease 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "NIL BY MOUTH AND SWALLOWING DIFFICULTY GUIDELINES FOR PARKINSON'S INPATIENTS"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "19018"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Ward Doctors / Specialist Nursing Staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "th 6 December 2019"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "th5 December 2022"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Trust requirements / Best Practice / NICE Guideline CG35 (2018)"
                    },
                    {
                        "text": "Contributes to CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "10,11,12,17"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Medicine & Emergency Care"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Amira Chaudry, Lead ED Pharmacist Vicky Glynn, Clinical Nurse Specialist Dr V. Kurien Thyparambil, Medical Consultant - Elderly Care and Consultant Lead for Dementia and Delirium; Safeguarding Lead"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\uf0fcMEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Medicines Optimisation & Medication Safety Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "23rd October 2019"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dr Ravi Dasari, Consultant Neurologist"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "20th November 2019"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Document Ratification Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "28th November 2019"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: December 2019"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Trust Intranet/ Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "19018 Inpatient Management of Parkinsons Disease 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Alison Felton"
                    },
                    {
                        "text": "Head of Pharmacy"
                    },
                    {
                        "text": "23rd October 2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "04071 Standard Infection Prevention Precautions 04072 Hand Hygiene Policy 08086 Clinical Record Keeping Standards Policy 10081 Dementia Policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 14,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Vicky Glynn / Dr Kurien Thyparambil / Amira Chaudry"
                    },
                    {
                        "text": "Newly created"
                    },
                    {
                        "text": "6th December 2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Index"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 0,
                "text": "Appendix 1: Initial Management of Patients with Parkinson's Disease who are"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 0,
                "text": "Nil by Mouth or who have swallowing difficulties"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 0,
                "text": "Table1: Management of Parkinson's disease patients with swallowing difficulties or"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 0,
                "text": "feeding tubes in situ"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 0,
                "text": "Table 2: Rotigotine conversion table if only on levodopa (with or without COMT"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 0,
                "text": "inhibitor) preparation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "text": "Table 3: Switching guidelines from a single oral dopamine agonist to Rotigotine"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 0,
                "text": "transdermal patch"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "text": "Appendix 2: Parkinson's Medication available in Emergency Department Appendix 3: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 1.1,
                "text": "To be used by non-specialists to support prescribing, dispensing and administration of medicines for patients with Parkinson's disease with swallowing difficulties or a feeding tube in situ, whilst awaiting specialist review."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 1,
                "prefix": 2.1,
                "text": "This guideline is for use in all patients who are receiving active treatment for Parkinson's disease who develop swallowing difficulties or have a feeding tube in situ."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 1,
                "prefix": 2.2,
                "text": "It is the responsibility of the prescribing doctor to ensure the guideline is followed and that appropriate treatment is prescribed for the patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 1,
                "prefix": 3.1,
                "text": "Parkinson's disease is a progressive degenerative neurological disorder associated with loss of dopamine producing neurones in the substantia nigra."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 1,
                "prefix": 3.2,
                "text": "The main features of Parkinson's disease are:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "text": "Slowness of movement;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "text": "Muscle rigidity;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "text": "Tremor;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "text": "Postural instability (later stages)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "Parkinson's disease is a condition which affects movement and motor function but it is also a condition which causes many non-motor symptoms (depression, anxiety and pain)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 3.4,
                "text": "Medication is crucial in optimising management of Parkinson's disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "prefix": 3.5,
                "text": "The patient's condition will deteriorate significantly if medication cannot be given."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "prefix": 3.6,
                "text": "Missed doses can put the patient at risk of neuroleptic malignant like syndrome."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "prefix": 3.7,
                "text": "The guideline provides information on alternative treatment options and method of administration when a solid oral dosage form cannot be administered via the oral route."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "prefix": 3.8,
                "text": "Each regimen must be reviewed on an individual basis with the intention of returning the patient back to their original oral regimen as soon as possible."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Initial Management of Patient's with Parkinson's Disease who are Nil by Mouth or who have Swallowing Difficulties"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "It is crucial to continue Parkinson's Disease medication as there is a risk of neuroleptic malignant like syndrome."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "Ensure accurate medication reconciliation and that medication is correctly prescribed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "Assess patient's swallow early and ensure provision of medication via alternative route ASAP if any concerns."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix 1 for management algorithm)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "Each patient must be reviewed on an individual basis. A review should be completed every 24 hours with the aim of reverting the patient back to their original regimen of oral medications as soon as possible."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "Check contra-indicated medication is NOT prescribed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Risks of Omitting Parkinson's Medication"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Deterioration of swallow \u2013 higher than normal risk of aspiration and aspiration pneumonia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 1,
                "prefix": 5.2,
                "text": "Exacerbation of Parkinson's symptoms \u2013 motor (mobility, self-care, falls risk) and non-motor (pain, anxiety, lack of concentration and focus, slowness of thought)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Deterioration in longer term Parkinson's control \u2013 can result permanent reduction in mobility."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Neuroleptic Malignant Syndrome \u2013 pyrexia, fever, confusion, raised CPK, muscle rigidity, altered consciousness."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "Death \u2013 patients with Parkinson's have greater in-hospital mortality. Ensuring patients receive their usual medication and timely specialist review will reduce this risk."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Management of complications associated with Parkinson's Disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Delirium:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "text": "Avoid typical antipsychotics which are contraindicated and may worsen motor symptoms;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "text": "Use lorazepam first line in an acute phase of delirium or acute confusion. If longer term treatment is indicated consider atypical antipsychotics;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "Avoid risperidone and olanzapine as they may have a higher risk of worsening Parkinon's;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "text": "Ensure patient not on any anti-cholinergic medication (which can worsen delirium)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Lower respiratory tract infection:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "Early physiotherapy, sitting out and mobilisation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "Constipation:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "text": "Constipation will affect medication absorption;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "text": "Treat aggressively with macrogol laxative;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "text": "Ensure adequate hydration."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "Urinary Tract Infection:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "text": "Ensure adequate hydration;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "Consider community-based anticipatory for future management if cause of recurrent admissions."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "Orthostatic hypotension:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "text": "Ensure adequate hydration and salt intake;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "text": "Rationalise anti-hypertensive medication;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "text": "Consider compression hosiery (if not contra-indicated);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "text": "Consider fludrocortisone."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "prefix": 6.6,
                "text": "High falls risk:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "text": "Treat any underlying orthostatic hypotension;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "text": "Ensure early physio review;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "Consider bone health."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Contra-indicated Medications in Parkinson's Disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Typical antipsychotics."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Centrally acting anti-emetics (metoclopramide, cyclizine, prochlorperazine) can worse Parkinson's Disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "Anti-cholinergics can worsen confusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Pharmacy \u2013 Supplies/ Stock Location"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "During working hours patient's medication can be ordered from Pharmacy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 1,
                "prefix": 8.2,
                "text": "Out of hours Emergency Parkinson's medication can be obtained from the Parkinson's"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 1,
                "text": "shelf in ED Majors. Speak to the Nurse in Charge about accessing this medication. (Refer to Appendix 2 for the list of medications which are stocked here)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Useful Contact details"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Parkinson's Disease Clinical Specialists on extension 4438."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "Medicines Information on extension 4822."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "On-call pharmacist (out of hours) via switchboard."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Staff and Training Requirements"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "All medical and nursing staff are to ensure that their knowledge, competencies and skills are up to date."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "During induction, staff will receive instruction on current policies and guidelines and how to access them."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "On approval by the Document Ratification Group (DRAG) this guideline will be uploaded to the Trust Intranet."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix 3)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Pharmacy will review prescriptions of patients with Parkinson's Disease during routine ward visits and when reviewing charts in dispensary. Any concerns will be reported to the physician responsible for the patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "text": "NICE Guideline CG35"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "SIGN 113 Diagnosis and pharmacological management of Parkinson's disease. January 2010"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "NICE \u2013 National cost-impact report"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "Parkinson's UK. \u201cGet it on time\u201d campaign. www.parkinsons.org.uk/about_us/policy_and_campaigns- 1/campaigns/get_it_on_time_campaign.aspx"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "Reid J. Acute management of Parkinson's disease (Clinical guidelines). Fife Parkinson's Service 2011"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "text": "Goff A, Jackson S. Parkinson's UK Patient Survey and Medicines' Management Audit in The Royal Devon and Exeter Hospital, UK, 2011. Parkinsonism and Related Disorders. January 2012. 2.225"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "text": "Pepper PV, Goldstein MK. Postoperative complications in Parkinson's disease. JAGS 1999;47:967-972"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "Brennan KA, Genever RW. Managing Parkinson's disease during surgery. BMJ 2010; 341:990-993"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "text": "Galvez-Jiminez N, Land AE. The perioperative management of Parkinson's disease revisited. Neurol Clin N America 2004; 22:367-377"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "text": "Patel SG et al. How should Parkinson's disease be managed perioperatively? The Hospitalist 2012"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "text": "Wullner U et al. Transdermal rotigotine for the perioperative management of Parkinson's disease. J Neural Transm 2010; 117:855-85"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "text": "Han-Joon K et al. Overnight switch from ropinorole to transdermal rotigotine patch in patients with Parkinson's disease. BMC Neurology 2011; 11:100"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "text": "Fox, Naomi. \u201cDevelopment of the OPTIMAL online guideline and calculator for Parkinson's medication in inpatients\u201d, PD Academy Masterclass Newsletter - Moving On"
            }
        },
        {
            "type": "image",
            "sequence_num": 107,
            "data": {
                "url": "19018 Inpatient Management of Parkinsons Disease 1.0.003.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 1,
                "text": "Table 1: Management of Parkinson's disease patients with swallowing difficulties or feeding tubes in situ"
            }
        },
        {
            "type": "table",
            "sequence_num": 109,
            "data": {
                "num_rows": 14,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Medicine"
                    },
                    {
                        "text": "Formulation"
                    },
                    {
                        "text": "Recommendation"
                    },
                    {
                        "text": "Example"
                    },
                    {
                        "text": "Co-Beneldopa (Madopar)"
                    },
                    {
                        "text": "Dispersible tablets"
                    },
                    {
                        "text": "Continue no change required"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Capsules"
                    },
                    {
                        "text": "Use dispersible tablets"
                    },
                    {
                        "text": "Co-Beneldopa (any dose) is equivalent to Co-beneldopa Dispersible"
                    },
                    {
                        "text": "Modified Release Tablets"
                    },
                    {
                        "text": "Keeping the same total daily levodopa dose convert to dispersible tablets. The frequency may need to be altered."
                    },
                    {
                        "text": "Madopar CR 125 ON would be changed to Co-Beneldopa dispersible 125 ON"
                    },
                    {
                        "text": "Co-Careldopa (Sinemet)"
                    },
                    {
                        "text": "Tablets (Plain release)"
                    },
                    {
                        "text": "Continue current regime \u2013 plain release tablets will disperse in water OR switch to equivalent levodopa dose of dispersible Co-Beneldopa"
                    },
                    {
                        "text": "Co-Careldopa (any dose) is equivalent to Co-beneldopa Dispersible"
                    },
                    {
                        "text": "Modified Release Tablets"
                    },
                    {
                        "text": "Keeping the same total daily levodopa dose convert to dispersible tablets OR switch to equivalent levodopa dose of dispersible Co- Beneldopa divided in 3 or more daily doses."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Pramipexole"
                    },
                    {
                        "text": "Tablets (Plain Release)"
                    },
                    {
                        "text": "Continue current regime, plain release tablets will disperse in 15- 30mL of water."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Modified Release Tablets"
                    },
                    {
                        "text": "Convert to plain release tablets. Covert to TDS regime."
                    },
                    {
                        "text": "Pramipexole MR 2.1mg OD would be changed to Pramipexole 0.7mg TDS"
                    },
                    {
                        "text": "Ropinirole"
                    },
                    {
                        "text": "Tablet (Plain Release)"
                    },
                    {
                        "text": "Continue current regime, plain release tablets will disperse in 10mL of water."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Modified Release Tablets"
                    },
                    {
                        "text": "Convert to plain release tablets. Convert total daily dose to TDS regime."
                    },
                    {
                        "text": "Ropinirole XL 24mg OD would be changed to Ropinirole 8mg TDS"
                    },
                    {
                        "text": "Rasagiline"
                    },
                    {
                        "text": "Tablets"
                    },
                    {
                        "text": "Continue current regime, plain release tablets will disperse in 15- 30mL of water."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Selegeline"
                    },
                    {
                        "text": "Tablets"
                    },
                    {
                        "text": "Continue current regime, plain release tablets will disperse in 15- 30mL of water."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Orodispersible tablets (Selegiline lyophilisate)"
                    },
                    {
                        "text": "1.25mg of orodispersible tablets is equivalent to 10mg standard tablet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Entacapone"
                    },
                    {
                        "text": "Tablets"
                    },
                    {
                        "text": "Continue current regime. Place tablet in an oral syringe and add"
                    },
                    {
                        "text": "The Entacapone component can be safely omitted from"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 110,
            "data": {
                "num_rows": 3,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "10ml of water. It will disperse slowly. The dispersion will stain and therefore crushing tablets to a dry powder should be avoided"
                    },
                    {
                        "text": "patient's regimen"
                    },
                    {
                        "text": "Stalevo Co-Careldopa + Entacapone"
                    },
                    {
                        "text": "Tablets"
                    },
                    {
                        "text": "Continue current regime but consider changing prescription to individual components (Co-Careldopa + Entacapone) \u2013 see above for further details. If NG tube switch Co-Careldopa to dispersible Co-beneldopa."
                    },
                    {
                        "text": "Stalevo 100 OD could be converted to Madopar Dispersible 125 OD."
                    },
                    {
                        "text": "Amantadine"
                    },
                    {
                        "text": "Capsules"
                    },
                    {
                        "text": "Continue current regime, capsules can be opened and contents will dissolve in water"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 1,
                "text": "Table 2: Rotigotine conversion table if only on levodopa (with or without"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 1,
                "text": "COMT inhibitor) preparation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "text": "Caution needs to be exercised as it can cause nausea, vomiting, skin reaction, hypotension, hallucinations and increased confusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "text": "Caution and lower doses are required in patients with dementia/ delirium"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "text": "Once commenced on the patch the strength needs to be monitored on a regular basis \u2013 consider putting the patient back on usual drug regime at the earliest available opportunity"
            }
        },
        {
            "type": "table",
            "sequence_num": 116,
            "data": {
                "num_rows": 15,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Current Levodopa regime"
                    },
                    {
                        "text": "Rotigotine patch equivalent"
                    },
                    {
                        "text": "Madopar or Sinemet 62.5 mg BD"
                    },
                    {
                        "text": "2 mg /24 hours"
                    },
                    {
                        "text": "Madopar or Sinemet 62.5 mg TDS"
                    },
                    {
                        "text": "4mg /24 hours"
                    },
                    {
                        "text": "Madopar or Sinemet 62.5 mg QDS"
                    },
                    {
                        "text": "6 mg /24 hours"
                    },
                    {
                        "text": "Madopar or Sinemet 125 mg TDS"
                    },
                    {
                        "text": "8 mg /24 hours"
                    },
                    {
                        "text": "Madopar or Sinemet 125 mg QDS"
                    },
                    {
                        "text": "10 mg /24 hours"
                    },
                    {
                        "text": "Madopar or Sinemet 187.5 mg TDS"
                    },
                    {
                        "text": "12 mg /24 hours"
                    },
                    {
                        "text": "Madopar or Sinemet 187.5 mg QDS"
                    },
                    {
                        "text": "14 mg /24 hours"
                    },
                    {
                        "text": "Madopar or Sinemet 250 mg TDS"
                    },
                    {
                        "text": "16 mg /24 hours"
                    },
                    {
                        "text": "Madopar or Sinemet 250 mg QDS"
                    },
                    {
                        "text": "16 mg /24 hours"
                    },
                    {
                        "text": "Stalevo 50/12.5/200 TDS"
                    },
                    {
                        "text": "6 mg /24 hours"
                    },
                    {
                        "text": "Stalevo 100/25/200 TDS"
                    },
                    {
                        "text": "10 mg /24 hours"
                    },
                    {
                        "text": "Stalevo 100/25/200 QDS"
                    },
                    {
                        "text": "14 mg /24 hours"
                    },
                    {
                        "text": "Stalevo 150/37.5/200 TDS"
                    },
                    {
                        "text": "16 mg /24 hours"
                    },
                    {
                        "text": "Stalevo 200/50/200 TDS"
                    },
                    {
                        "text": "16 mg /24 hours"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "text": "Maximum dose of Rotigotine is 16mg/24 hours"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "Do not cut patches to achieve the correct dose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 1,
                "text": "Caution and lower doses are required in patients with dementia/ delirium"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 1,
                "text": "Table 3: Switching guidelines from a single oral dopamine agonist to Rotigotine transdermal patch"
            }
        },
        {
            "type": "table",
            "sequence_num": 121,
            "data": {
                "num_rows": 8,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Pramipexole (salt concentration)"
                    },
                    {
                        "text": "Ropinirole Standard Release (Requip)"
                    },
                    {
                        "text": "Ropinirole Modified Release (Requip XL)"
                    },
                    {
                        "text": "Rotigotine transdermal patch"
                    },
                    {
                        "text": "0.125mg TDS"
                    },
                    {
                        "text": "Starter pack"
                    },
                    {
                        "text": "NA"
                    },
                    {
                        "text": "2 mg /24 hours"
                    },
                    {
                        "text": "0.25mg TDS"
                    },
                    {
                        "text": "1mg TDS"
                    },
                    {
                        "text": "4mg/ day"
                    },
                    {
                        "text": "4mg /24 hours"
                    },
                    {
                        "text": "0.5mg TDS"
                    },
                    {
                        "text": "2mg TDS"
                    },
                    {
                        "text": "6mg/ day"
                    },
                    {
                        "text": "6 mg /24 hours"
                    },
                    {
                        "text": "0.75mg TDS"
                    },
                    {
                        "text": "3mg TDS"
                    },
                    {
                        "text": "8mg/ day"
                    },
                    {
                        "text": "8 mg /24 hours"
                    },
                    {
                        "text": "1mg TDS"
                    },
                    {
                        "text": "4mg TDS"
                    },
                    {
                        "text": "12mg/ day"
                    },
                    {
                        "text": "10-12mg /24 hours"
                    },
                    {
                        "text": "1.25mg TDS"
                    },
                    {
                        "text": "6mg TDS"
                    },
                    {
                        "text": "16mg/ day"
                    },
                    {
                        "text": "14 mg /24 hours"
                    },
                    {
                        "text": "1.25mg TDS"
                    },
                    {
                        "text": "8mg TDS"
                    },
                    {
                        "text": "24mg/ day"
                    },
                    {
                        "text": "16 mg /24 hours"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "text": "Maximum dose of Rotigotine is 16mg/24 hours"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "text": "Do not cut patches to achieve the correct dose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 1,
                "text": "Caution and lower doses are required in patients with dementia/ delirium"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 1,
                "text": "APPENDIX 2:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 1,
                "text": "Parkinson's Disease Medication available in ED"
            }
        },
        {
            "type": "table",
            "sequence_num": 127,
            "data": {
                "num_rows": 19,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Generic"
                    },
                    {
                        "text": "Brand"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Levodopa (Standard Release Preparations)"
                    },
                    {
                        "text": "Co-Careldopa 12.5/50 Tablets"
                    },
                    {
                        "text": "Sinemet 62.5"
                    },
                    {
                        "text": "Co-Careldopa 25/100 Tablets"
                    },
                    {
                        "text": "Sinemet Plus"
                    },
                    {
                        "text": "Co-Beneldopa 12.5/50 Capsules"
                    },
                    {
                        "text": "Madopar"
                    },
                    {
                        "text": "Co-Beneldopa 12.5/50 Dispersible Tablets"
                    },
                    {
                        "text": "Madopar"
                    },
                    {
                        "text": "Co-Beneldopa 25/100 Capsules"
                    },
                    {
                        "text": "Madopar"
                    },
                    {
                        "text": "Levodopa (Modified Release Preparations)"
                    },
                    {
                        "text": "Co-Careldopa 25/100 Modified Release Tablets"
                    },
                    {
                        "text": "Half Sinemet CR"
                    },
                    {
                        "text": "Co-Beneldopa 25/100 Modified Release Capsules"
                    },
                    {
                        "text": "Madopar CR"
                    },
                    {
                        "text": "Rotigotine (Neupro) Patches"
                    },
                    {
                        "text": "Rotigotine 2mg/24hours Patches"
                    },
                    {
                        "text": "Neupro"
                    },
                    {
                        "text": "Rotigotine 4mg/24hours Patches"
                    },
                    {
                        "text": "Neupro"
                    },
                    {
                        "text": "Rotigotine 4mg/24hours Patches"
                    },
                    {
                        "text": "Neupro"
                    },
                    {
                        "text": "Dopamine Agonists, COMT inhibitors and others"
                    },
                    {
                        "text": "Entacapone 200mg Tablets"
                    },
                    {
                        "text": "Comtess"
                    },
                    {
                        "text": "Pramipexole 88 micrograms (base) Tablets"
                    },
                    {
                        "text": "Mirapexin"
                    },
                    {
                        "text": "Pramipexole 180 micrograms (base) Tablets"
                    },
                    {
                        "text": "Mirapexin"
                    },
                    {
                        "text": "Pramipexole 700 micrograms (base) Tablets"
                    },
                    {
                        "text": "Mirapexin"
                    },
                    {
                        "text": "Pramipexole 260 micrograms modified release Tablets"
                    },
                    {
                        "text": "Mirapexin"
                    },
                    {
                        "text": "Rasagiline 1mg Tablets"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Ropinirole 1mg Tablets"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 128,
            "data": {
                "num_rows": 18,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "text": "Inpatient Management of Parkinsons Disease/19018/ 1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "text": "Inpatient Management of Parkinsons Disease/19018/ 1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Inpatient Management of Parkinson's Disease/19018"
            }
        },
        {
            "type": "table",
            "sequence_num": 134,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Service Requirement"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients & Clinicians"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Yes Refer to pages 1 & 2 consultation"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 136,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Vicky Glynn"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Clinical Nurse Specialist"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "November 2019"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Page  of"
            }
        }
    ]
}